3580
Z. MALINOWSKI ET AL.
REFERENCES
1. Kuroda, S.; Takamura, F.; Tenda, Y.; Itani, H.; Tomishima, Y.; Akahane, A.; Sakane, K.
Design, synthesis, and biological evaluation of a novel series of potent, orally active ade-
nosine A1 receptor antagonists with high blood–brain barrier permeability. Chem. Pharm.
Bull. 2001, 49, 988–998.
2. Dal Piaz, V.; Cianini, G.; Turco, G.; Giovannoni, M.P.; Mideli, M.; Pirisino, R.; Perretti,
M. 5-Acyl-6-aryl-4-nitro-3(2H)-pyridazinones and related 4-amino compounds: synthesis
and pharmacological evaluation. J. Pharm. Sci. 1991, 80, 341–348.
3. Dal Piaz, V.; Giovannoni, M. P.; Ciciani, G.; Barlocco, D.; Giardina, G.; Petrone, G.;
Clarke, G. D. 4,5-Functionalized 6-phenyl-3(2H)-pyridazinones: synthesis and evaluation
of antinociceptive activity. Eur. J. Med. Chem. 1996, 31, 65–70.
4. Takaya, M.; Sato, M.; Terashima, H.; Tanizawa, H.; Maki, Y. A new nonsteroidal
analgesic-antiinflammatory agent: Synthesis and activity of 4-ethoxy-2-methyl-
5-morpholino-3(2H)-pyridazinone and related compounds. J. Med. Chem. 1979, 22,
53–58.
5. Montesano, F.; Barlocco, D.; Dal Piaz, V.; Leonardi, A.; Poggesi, E.; Fanelli, F.; De
Benedetti, P. G. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding
4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for a1-adrenoceptor
selective antagonists: synthesis, modeling, and binding studies. Bioorg. Med. Chem.
1998, 6, 925–935.
6. (a) Strappaghetti, G.; Brodi, C.; Giannaccini, G.; Betti, L. New 4-(4-methyl-phenyl)
phthalazin-1(2H)-one derivatives and their effects on a1-receptors. Bioorg. Med. Chem.
Lett. 2006, 16, 2575–2579 (b) Betti, L.; Botta, M.; Corelli, F.; Floridi, M.; Fossa, P.;
Giannaccini, G.; Manetti, F.; Strappaghetti, G.; Corsano, S. a1-Adrenoceptor antago-
nists: Rational design, synthesis and biological evaluation of new trazodone-like
compounds. Bioorg. Med. Chem. Lett. 2002, 12, 437–440.
7. Tsubaki, K.; Taniguchi, K.; Tabuchi, S.; Okitsu, O.; Hattori, K.; Seki, J.; Sakanea, K.;
Tanaka, H. A novel pyridazinone derivative as a nonprostanoid PGI2 agonist. Bioorg.
Med. Chem. Lett. 2000, 10, 2787–2790.
8. Rohet, F., Rubat, C.; Coudert, P.; Albuisson, E.; Couquelet, J. Synthesis and
4-phenyl-6-aryl-2-[3-(4-arylpiperazin-1-
trazodone-like
analgesic
activity
yl)propyl]pyriazin-3-ones. Chem. Pharm. Bull. 1996, 44, 980–986.
of
9. Gokce, M.; Dogruer, D.; Fethi Sahin, M. Synthesis and antinociceptive activity of
6-substituted-3-pyridazinone derivatives. Farmaco 2001, 56, 233–237.
10. Dal Piaz, V.; Vergelli, C.; Giovannoni, M. P.; Scheideler, M. A.; Petrone, G.; Zaratin, P.
4-Amino-3(2H)-pyridazinones bearing arylpiperazinylalkyl groups and related
compounds: Synthesis and antinociceptive activity. Farmaco 2003, 58, 1063–1071.
´
11. Pakulska, W.; Malinowski, Z.; Szczesniak, A. K.; Czarnecka, E.; Epsztajn, J. Synthesis
and pharmacological evaluation of N-(dimethylamino)ethyl derivatives of benzo- and
pyridopyridazinones. Arch. Pharm. Chem. Life Sci. 2009, 342, 41–47.
12. Epsztajn, J.; Malinowski, Z.; Urbaniak, P.; Andrijewski, G. A practical approach for
preparation of 2-[(dialkylamino)-methyl]-4-aryl-2H-phthalazin-1-ones via Mannich reac-
tion of 4-aryl-2H-phthalazin-1-ones. Synth. Commun. 2005, 35, 179–192.
´
13. Brzezinski, J.; Epsztajn, J.; Bakalarz, A. D.; Łajszczak, A.; Malinowski, Z. Application of
organolithium and related reagents in synthesis, part 22: Synthetic strategies based on
ortho-aromatic metallation: A concise regiospecific conversion of benzoic acids into the
4-pyridyl-2H-phthalazin-1-ones. Synth. Commun. 1999, 29, 457–473.
´
14. Epsztajn, J.; Malinowski, Z.; Brzezinski, J.; Karzatka, M. Application of organolithium
and related reagents in synthesis, part 26: Synthetic strategies based on directed ortho-
metalation: Synthesis of 4-methyl-2H-phthalazin-1-ones. Synthesis 2001, 14, 2085–2090.